Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Outcome Prediction
100%
Pseudomonas Aeruginosa Bacteraemia
100%
Piperacillin-tazobactam
100%
Classification and Regression Tree
28%
Regression Tree Analysis
28%
Classification Tree Analysis
28%
Clinical Outcomes
14%
Hospitalization
14%
Polymicrobial Infection
14%
Odds Ratio
14%
Patient Survival
14%
Improved Survival
14%
Adult Patients
14%
Pseudomonas Aeruginosa Infection
14%
Excess Mortality
14%
Hospital Survival
14%
β-lactamase Inhibitor
14%
Free Fraction
14%
Collection Time
14%
Inhibitor Combination
14%
Bacterial Killing
14%
Pharmacodynamic Target
14%
95% Confidence Interval
14%
Pharmacokinetic/pharmacodynamic (PK/PD)
14%
Clinical Covariates
14%
Beta-lactams
14%
Pharmacodynamic Parameters
14%
Infection-associated
14%
Nursing and Health Professions
Bloodstream Infection
100%
Piperacillin Plus Tazobactam
100%
Minimum Inhibitory Concentration
100%
Infection
33%
Pharmacodynamics
33%
Mortality Rate
16%
Odds Ratio
16%
Confidence Interval
16%
Clinical Outcome
16%
Penicillinase
16%
Lactam
16%
Pseudomonas Infection
16%
Free Fraction
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas aeruginosa
100%
Bloodstream Infection
100%
Piperacillin Plus Tazobactam
100%
Infection
33%
Pharmacodynamics
33%
Mortality Rate
16%
Retrospective Study
16%
Lactam
16%
Pseudomonas Infection
16%
Penicillinase
16%
Free Fraction
16%
Pharmacokinetics
16%
Immunology and Microbiology
Pseudomonas aeruginosa
100%
Minimum Inhibitory Concentration
100%
Infectious Disease
40%
Pharmacodynamics
40%
Infection
40%
Mortality Rate
20%
Bactericidal Activity
20%
Pharmacokinetics
20%
Polymicrobial Infection
20%
In Vitro
20%